awmsg logo



tocofersolan (Vedrop®)


Reference No. 1180

Publication date:
13/10/2011


Appraisal information

tocofersolan (Vedrop®) 50 mg/ml oral solution


Company: Orphan Europe (UK) Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 11/10/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, tocofersolan (Vedrop®) cannot be endorsed for use within NHS Wales for the treatment of vitamin E deficiency due to digestive malabsorption in paediatric patients suffering from congenital chronic cholestasis or hereditary chronic cholestasis, from birth (in term newborns) to 16 or 18 years of age, depending on the region.
Statement of Advice (SOA)
Download